[SYRS] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
16-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 0.73%
YoY- -66.14%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue -5,467 3,891 6,276 5,467 7,802 5,697 5,162 -
PBT -4,774 -30,253 -34,481 -25,146 -23,813 -26,027 -22,490 -64.31%
Tax -32,349 -9,201 712 -1,507 986 984 969 -
NP 27,575 -21,052 -35,193 -23,639 -23,813 -26,027 -22,490 -
Tax Rate - - - - - - - -
Total Cost -33,042 24,943 41,469 29,106 31,615 31,724 27,652 -
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -504.39 -541.04 -560.76 -432.39 -305.22 -456.85 -435.68 10.22%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS 0.99 -2.24 -5.51 -3.75 -3.78 -4.14 -3.60 -
EPS Diluted 0.99 -2.24 -5.51 -3.75 -3.78 -4.14 -3.58 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.